Physician profile
Daniel Delgadillo
NPI 1689984130
$11,416.19
in general payments reported to CMS, 2019-2025
6 companies · $3,500 in 2025
The $3,500 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $121 · 2023: $1,225 · 2024: $6,570 · 2025: $3,500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,657 · Travel and Lodging: $3,499 · Grant: $2,000 · Education: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,656.83 |
| Travel and Lodging | $3,498.54 |
| Grant | $2,000.00 |
| Education | $139.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,318.91 | 2023-2025 | Endurant Iis, Valiant Captivia, In.Pact Admiral |
| Shockwave Medical, INC | $746.56 | 2022-2025 | |
| Boston Scientific Corporation | $152.05 | 2024-2025 | Accolade Sr, Eluvia |
| Bolton Medical INC | $109.89 | 2024 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Stryker Corporation | $48.09 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Philips North America LLC | $40.69 | 2024 | (9520) Igt Devices Undivided |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Delgadillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.